BioMérieux
Top Five Articles on 360Dx Last Week: Qiagen Respiratory Test Cleared; Eurofins Acquisition; More
Last week, readers were most interested in a story about the FDA's clearance of Qiagen's QiaStat-Dx Respiratory Panel Mini syndromic multiplex qPCR test.
BioMérieux Gets CE Mark for B12 Assay
The assay measures total B12 in blood serum or plasma and runs on the firm's Vidas line of immunoanalyzers.
T2 Biosystems Pathogen Detection Patent Upheld in Europe
French diagnostics maker BioMérieux and other undisclosed firms had filed an opposition to the patent in May 2023.
BioMérieux Q2 Revenues Rise 8 Percent
The firm raised its full-year 2024 guidance to sales growth at constant exchange rates of 8 percent to 10 percent, up from previous guidance of 6 percent to 8 percent growth.
At the ADLM annual meeting, firms said they see game-changing opportunities for platforms that provide the right combination of clinical utility and convenience.